At Osteosarcoma Now, our mission has always been to make trusted information about osteosarcoma accessible to everyone. Today, we are proud to relaunch our Clinical Trial Explorer (ONTEX) following a major redevelopment that transforms how clinical trial information is presented.
The updated platform uses AI to automate the processing of clinical trial data, creating clear, patient-friendly summaries while helping to keep information accurate and up to date. This means patients, families and healthcare professionals can spend less time navigating complex trial listings and more time understanding potential treatment opportunities.
The enhanced Clinical Trial Explorer allows users to search for osteosarcoma clinical trials from around the world using filters such as location, age, recruitment status, treatment type and trial phase. Each study is presented in a format that is easier to understand, helping users prepare for informed conversations with their healthcare team.
This redevelopment is about more than technology. It is about making clinical research more accessible and ensuring that everyone affected by osteosarcoma has access to information they can understand and trust.
Clinical trials play a vital role in advancing treatment and improving outcomes. While participation is not suitable for everyone, having access to clear, reliable information empowers patients and families to explore the options available to them.
The Clinical Trial Explorer will continue to evolve as new research emerges, ensuring it remains a valuable, free resource for the global osteosarcoma community.
We invite you to explore the updated platform and, if you find it useful, help us reach more people by sharing it with your networks.
